BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18177861)

  • 1. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
    Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
    Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
    Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
    Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.
    Tran H; Gourrier N; Lemercier-Neuillet C; Dhaenens CM; Vautrin A; Fernandez-Gomez FJ; Arandel L; Carpentier C; Obriot H; Eddarkaoui S; Delattre L; Van Brussels E; Holt I; Morris GE; Sablonnière B; Buée L; Charlet-Berguerand N; Schraen-Maschke S; Furling D; Behm-Ansmant I; Branlant C; Caillet-Boudin ML; Sergeant N
    J Biol Chem; 2011 May; 286(18):16435-46. PubMed ID: 21454535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered splicing of Tau in DM1 is different from the foetal splicing process.
    Ghanem D; Tran H; Dhaenens CM; Schraen-Maschke S; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML
    FEBS Lett; 2009 Feb; 583(4):675-9. PubMed ID: 19166838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
    Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
    Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
    Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
    Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
    PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.
    Paul S; Dansithong W; Jog SP; Holt I; Mittal S; Brook JD; Morris GE; Comai L; Reddy S
    J Biol Chem; 2011 Nov; 286(44):38427-38438. PubMed ID: 21900255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1.
    Coleman SM; Prescott AR; Sleeman JE
    Biochem J; 2014 Mar; 458(2):267-80. PubMed ID: 24354850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
    Leroy O; Dhaenens CM; Schraen-Maschke S; Belarbi K; Delacourte A; Andreadis A; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML
    J Neurosci Res; 2006 Sep; 84(4):852-9. PubMed ID: 16862542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
    Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.